VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ITOC 2022 | CAR-T cells expressing a scFV targeting the hTSHR in thyroid cancer

Mascha Binder, MD, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany, discusses the generation of CAR-T cells expressing a scFV targeting the hTSHR in thyroid cancer. This interview took place at the Immunotherapy of Cancer (ITOC) Conference 2022 in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter